Your browser doesn't support javascript.
loading
PEG-Benzaldehyde-Hydrazone-Lipid Based PEG-Sheddable pH-Sensitive Liposomes: Abilities for Endosomal Escape and Long Circulation.
Kanamala, Manju; Palmer, Brian D; Ghandehari, Hamidreza; Wilson, William R; Wu, Zimei.
Afiliação
  • Kanamala M; School of Pharmacy, The University of Auckland, Auckland, 1142, New Zealand.
  • Palmer BD; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, 1142, New Zealand.
  • Ghandehari H; Departments of Pharmaceutics and Bioengineering, Utah Center for Nanomedicine, University of Utah, Salt Lake City, Utah, USA.
  • Wilson WR; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, 1142, New Zealand.
  • Wu Z; School of Pharmacy, The University of Auckland, Auckland, 1142, New Zealand. z.wu@auckland.ac.nz.
Pharm Res ; 35(8): 154, 2018 May 31.
Article em En | MEDLINE | ID: mdl-29855807
ABSTRACT

PURPOSE:

To fabricate an acid-cleavable PEG polymer for the development of PEG-cleavable pH-sensitive liposomes (CL-pPSL), and to investigate their ability for endosomal escape and long circulation.

METHODS:

PEG-benzaldehyde-hydrazone-cholesteryl hemisuccinate (PEGB-Hz-CHEMS) containing hydrazone and ester bonds was synthesised and used to fabricate a dual pH-sensitive CL-pPSL. Non-cleavable PEGylated pH-sensitive liposome (pPSL) was used as a reference and gemcitabine as a model drug. The cell uptake and endosomal escape were investigated in pancreatic cancer Mia PaCa-2 cells and pharmacokinetics were studied in rats.

RESULTS:

The CL-pPSL showed accelerated drug release at endosomal pH 5.0 compared to pPSL. Compared to pPSL, CL-pPSL released their fluorescent payload to cytosol more efficiently and showed a 1.4-fold increase in intracellular gemcitabine concentration and higher cytotoxicity. In rats, injection of gemcitabine loaded CL-pPSL resulted in a slightly smaller Vd (149 ± 27 ml/kg; 170 ± 30 ml/kg) and shorter terminal T1/2 (5.4 ± 0.3 h; 5.8 ± 0.6 h) (both p > 0.05) but a significantly lower AUC (p < 0.01), than pPSL, due to the lower PEGylation degree (1.7 mol%) which means a 'mushroom' configuration of PEG. A five-time increase in the dose with CL-pPSL resulted in a 11-fold increase in AUC and a longer T1/2 (8.2 ± 0.5 h).

CONCLUSION:

The PEG-detachment from the CL-pPSL enhanced endosome escape efficiency compared with pPSL, without significantly compromising their stealth abilities.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Benzaldeídos / Preparações de Ação Retardada / Desoxicitidina / Hidrazonas / Lipossomos / Antimetabólitos Antineoplásicos Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Benzaldeídos / Preparações de Ação Retardada / Desoxicitidina / Hidrazonas / Lipossomos / Antimetabólitos Antineoplásicos Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article